3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
3
Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
1
Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer
1
Recurrence
1
Patient Preference
1
Neoplasms
1
Lymphoma, Non-Hodgkin
1
Inflammatory Breast Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
CD20-positive Hematological Malignancies
1
Bile Duct Neoplasms
1
Advanced Cancers
1
Interventions
pembrolizumab
5
Nivolumab
3
Cisplatin
3
Taxes
2
Paclitaxel
2
poly ICLC
1
fludarabine phosphate
1
fludarabine
1
abemaciclib
1
Risk Factors
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiation
1
Pemetrexed
1
Nimorazole
1
Injections
1
High-Intensity Focused Ultrasound Ablation
1
Erlotinib Hydrochloride
1
Docetaxel
1
Cyclophosphamide
1
Cetuximab
1
Carboplatin
1
Biological Products
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Squamous Cell
×
Injections, Subcutaneous
×
1 year
×
Clear all
No trials found.